| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 12/27/2001 | CA2805216A1 Antigenic polypeptides from staphylococcus |
| 12/27/2001 | CA2414010A1 Secreted redox proteins |
| 12/27/2001 | CA2413986A1 Gp354 nucleic acids and polypeptides |
| 12/27/2001 | CA2413959A1 Fusion proteins of mycobacterium tuberculosis |
| 12/27/2001 | CA2413866A1 Compositions and methods of monoclonal and polyclonal antibodies specific for t cell subpopulations |
| 12/27/2001 | CA2413450A1 Streptococcus antigens |
| 12/27/2001 | CA2413358A1 Curing method for pathologic syndrome and a medicinal preparation |
| 12/27/2001 | CA2413324A1 Treatment of central nervous system diseases by antibodies against glatiramer acetate |
| 12/27/2001 | CA2412901A1 Bispecific fusion protein and method of use for enhancing effector cell killing of target cells |
| 12/27/2001 | CA2411945A1 Chimeric human papillomavirus (hpv) l1 molecules and uses therefor |
| 12/27/2001 | CA2411912A1 Compositions and methods for treatment of candidiasis |
| 12/27/2001 | CA2411826A1 Liposomal encapsulation of chelated actinium-225 and uses thereof |
| 12/27/2001 | CA2411756A1 Mutation associated with epilepsy |
| 12/27/2001 | CA2411236A1 Combinations and compositions which interfere with vegf/vegf and angiopoietin/tie receptor function and their use (ii) |
| 12/27/2001 | CA2411102A1 Cold anti-cd20 antibody/radiolabeled anti-cd22 antibody combination |
| 12/27/2001 | CA2410864A1 Compositions comprising net-4 modulations and their use for treating neoplastic disease |
| 12/27/2001 | CA2410371A1 Methods for enhancing antibody-induced cell lysis and treating cancer |
| 12/27/2001 | CA2409781A1 Phosphodiesterases |
| 12/27/2001 | CA2409776A1 G-protein coupled receptors |
| 12/26/2001 | CN1328571A Human monoclonal antibodies to CTLA-4 |
| 12/26/2001 | CN1328567A Mammaglobin, a secreted mammary-specific breast cancer protein |
| 12/26/2001 | CN1328470A Chemokine receptor peptide vaccines for treatment and prevention of diabetes |
| 12/26/2001 | CN1328469A Use of parvovirus capsid particles in inhibition of cell proliferation and migration |
| 12/26/2001 | CA2350043A1 Novel melanocortin -4 receptor sequences and screening assays to identify compounds useful in regulating animal appetite and metabolic rate |
| 12/25/2001 | US6333406 Gene encoding protein antigens of Plasmodium falciparum and uses therefor |
| 12/25/2001 | US6333403 Nucleotide sequences coding polypeptide associated with tumors; for use in diagnosis and treatment of tumors |
| 12/25/2001 | US6333395 Exhibit anti-membrane fusion capability, antiviral activity, such as the ability to inhibit hiv transmission to uninfected cells |
| 12/25/2001 | US6333348 Use of docetaxel for treating cancers |
| 12/25/2001 | US6333174 Transforming a bacterial inoculant with a replicable plasmid having a double stranded dna, a tryptophan promoter, ribosome binding site, a translation start signal with structural genes coding a leade, culture with tryptophan |
| 12/25/2001 | US6333169 HER2 extracellular domain |
| 12/25/2001 | US6333168 Cloning, expression and uses of dorsalin-1 |
| 12/25/2001 | US6333164 Fungal antigens and process for producing the same |
| 12/25/2001 | US6333161 Assaying a test ligands ability to bind a central nervous system receptor by incubation the ligand with mutant cells that produce a kainate-binding excitatory amino acid receptor and determining the extent of binding |
| 12/25/2001 | US6333051 Nanogel networks and biological agent compositions thereof |
| 12/25/2001 | US6333038 Administering to an individual who has not been sensitized by environmental allergen a dose and form of allergen to induce estabilishment of stable population of allergen-specific t-helper-1-like memory lymphocytes |
| 12/25/2001 | US6333036 Vaccine composition containing polyribosylribitol phosphate and method for making same |
| 12/25/2001 | US6333035 Administering monoclonal antibody against a human t-cell leukemia virus-derived transcription activating factor p40tax-induced cell membrane glycoprotein of 34 kda (gp34) in an amount effective for treating rheumatoid arthritis |
| 12/25/2001 | US6333034 Administering anti-properdin agent effective to selectively inhibit formation of an alternative complement pathway activation product |
| 12/25/2001 | US6333033 Autoantibody inhibitors |
| 12/25/2001 | US6333032 Administering to antibody to gamma interferon in an amount effective to neutralize or reduce fluid activity levels of gamma interferon for therapy of multiple sclerosis, rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis |
| 12/25/2001 | US6333028 Administering autologous human ovarian carcinoma tumor cells conjugated with hapten, wherein the tumor cells have been treated to not grow and divide after administration to a subject |
| 12/25/2001 | CA2172779C Cgrp antagonist used for the treatment of pruritus and ocular or palpebral dysesthesia |
| 12/25/2001 | CA2139385C Products containing g-csf and tnf binding protein |
| 12/25/2001 | CA1341329C Determined dna sequences derived from a papilloma virus genome, their uses for in vitro diagnostic purposes and the production of antigenic compositions |
| 12/20/2001 | WO2001096587A2 Methods for administering recombinant adeno-associated virus virions to humans previously exposed to adeno-associated virus |
| 12/20/2001 | WO2001096566A1 Gasc1 gene |
| 12/20/2001 | WO2001096564A2 Hla-g (hla-g7) isoform and its applications |
| 12/20/2001 | WO2001096394A2 Pleiotrophin growth factor receptor for the treatment of proliferative, vascular and neurological disorders |
| 12/20/2001 | WO2001096393A2 Nucleotide and amino acid sequences of oocyte factors for altering ovarian follicular growth in vivo or in vitro |
| 12/20/2001 | WO2001096391A2 55p4h4: gene expressed in various cancers |
| 12/20/2001 | WO2001096388A2 Compositions and methods for the therapy and diagnosis of colon cancer |
| 12/20/2001 | WO2001096381A2 IMMUNIZATION OF DAIRY CATTLE WITH GapC PROTEIN AGAINST STREPTOCOCCUS INFECTION |
| 12/20/2001 | WO2001096380A2 IMMUNIZATION OF DAIRY CATTLE WITH Mig PROTEIN |
| 12/20/2001 | WO2001096379A2 Immunization of dairy cattle with chimeric gapc protein against streptococcus infection |
| 12/20/2001 | WO2001096377A2 Vaccine for congenital tremors in pigs |
| 12/20/2001 | WO2001096376A2 Pro-apoptotic fragments of the dengue virus envelope glycoproteins |
| 12/20/2001 | WO2001096368A2 Use of coiled-coil structural scaffold to generate structure-specific peptides |
| 12/20/2001 | WO2001095942A2 Pegylation of linkers improves antitumor activity and reduces toxicity of immunoconjugates |
| 12/20/2001 | WO2001095935A1 Immunostimulatory nucleic acids for inducing a th2 immune response |
| 12/20/2001 | WO2001095934A2 The use of plant oil-bodies in vaccine delivery systems |
| 12/20/2001 | WO2001095933A2 Immunization through oral administration of a vaccine with an edible product |
| 12/20/2001 | WO2001095928A2 Methods for regulating a cell-mediated immune response by blocking lymphocytic signals and by blocking lfa-1 mediated adhesion |
| 12/20/2001 | WO2001095926A1 Immunosuppressor agent derived from morbillivirus |
| 12/20/2001 | WO2001095919A2 A recombinant non-replicating virus expressing gm-csf and uses thereof to enhance immune responses |
| 12/20/2001 | WO2001095874A2 Highly efficient delivery of a large therapeutic mass aerosol |
| 12/20/2001 | WO2001088108A8 Neuronal serine-threonine protein kinase |
| 12/20/2001 | WO2001079259A8 Javelinization of protein antigens to heat shock proteins |
| 12/20/2001 | WO2001070764A3 Epitopes of mycobacterium tuberculosis secreted antigens and uses thereof |
| 12/20/2001 | WO2001064751A3 High potency recombinant antibodies and method for producing them |
| 12/20/2001 | WO2001055181A3 Recombinant multivalent malarial vaccines against plasmodium vivax |
| 12/20/2001 | WO2001054719A3 Vaccine for the prophylactic or therapeutic immunization against hiv |
| 12/20/2001 | WO2001052888A3 Improved dna vaccines for production-type animals |
| 12/20/2001 | WO2001052874A3 Intra-tumoral administration of il-12 encoding nucleic acid molecules |
| 12/20/2001 | WO2001051517A3 Candida hemolysin - like proteins and their uses |
| 12/20/2001 | WO2001048208A3 Streptococcus pyogenes virulence genes and proteins and their use |
| 12/20/2001 | WO2001046390A3 Method of inactivating microorganisms |
| 12/20/2001 | WO2001046389A3 Immature autologous clinical grade dendritic cells intended for vaccination of cancer patients |
| 12/20/2001 | WO2001040281A3 Method for reducing the immunogenicity of heterologous proteins by elimination of t-cell epitopes |
| 12/20/2001 | WO2001024833A3 In vivo assay for testing the phenotypic stability |
| 12/20/2001 | WO2001024822A3 Pharmaceutical composition comprising an antigen |
| 12/20/2001 | WO2000073432A3 Activation of dendritic cells to enhance immunity |
| 12/20/2001 | WO2000060076A3 Compositions for the treatment and diagnosis of breast cancer and methods for their use |
| 12/20/2001 | WO2000058358A9 49 human secreted proteins |
| 12/20/2001 | WO2000024765A8 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 12/20/2001 | US20010053844 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 12/20/2001 | US20010053536 cDNA clone HDPBI30 that encodes a novel human 7-transmembrane receptor |
| 12/20/2001 | US20010053371 Molecule having an IL13-moiety and a cytotoxic moiety; especially for reducing growth of glioblastoma multiforme cells. |
| 12/20/2001 | US20010053368 Proteosome influenza vaccine |
| 12/20/2001 | US20010053367 Vaccines expressed in plants |
| 12/20/2001 | US20010053366 Method of removing endotoxin from vaccines |
| 12/20/2001 | US20010053365 Vaccines |
| 12/20/2001 | US20010053364 Treating cholinergic controlled secretions including excessive sweating, lacrimation and mucus secretion; relieving pain associated with smooth muscle disorders, including spasms in the sphincter muscles; type A & B toxins |
| 12/20/2001 | US20010053363 Novel amphipathic aldehydes and their uses as adjuvants and immunoeffectors |
| 12/20/2001 | US20010053362 Tolerizing the immune system of a non-human animal with antigens from said subject, and thereafter transplanting the bone marrow of said subject with the bone marrow of said tolerized immune system. |
| 12/20/2001 | US20010053361 Immunotherapy involving cd28 stimulation |
| 12/20/2001 | US20010053358 Growth differentiation factor-11 |
| 12/20/2001 | US20010053357 Peptide having an amino acid sequence corresponding to an amino acid sequence of a V-domain of a receptor for advanced glycation endproduct. |
| 12/20/2001 | US20010053355 Treated monocytes incubated to maximize number of functional dendritic cells; then incubated with disease effector agents to enhance the presentation of at least one disease-causing antigen expressed by the disease effector agents. |
| 12/20/2001 | DE10027383A1 Nukleinsäure-Molekül umfassend eine für ein Chemokin, einen Neuropeptid-Präkursor oder mindestens ein Neuropeptid kodierende Nukleinsäuresequenz Nucleic acid molecule comprising a sequence coding for a chemokine, a neuropeptide precursor or at least one neuropeptide nucleic acid sequence |
| 12/20/2001 | DE10024171A1 Neuronale Serin-Threonin-Protein-Kinase Neuronal serine threonine protein kinase |